Cancer combo trial pulled before starting
NCT ID NCT05982522
First seen Apr 09, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study was designed to test a new drug (IN10018) combined with chemotherapy and immunotherapy in people with advanced solid tumors, like lung cancer, that had stopped responding to earlier treatments. The goal was to see if the combination could shrink tumors or slow their growth. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.